Sol-gel technologies reports first quarter 2022 financial results and provides corporate update

Ness ziona, israel, may 13, 2022 (globe newswire) -- sol-gel technologies, ltd. (nasdaq: slgl), a dermatology company focused on identifying, developing, commercializing or partnering branded and generic topical drug products for the treatment of skin diseases, announced today financial results for the first quarter ended march 31, 2022 and provided a corporate update.
SLGL Ratings Summary
SLGL Quant Ranking